TBL Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von TBL-Antikörpern für Forschungsanwendungen an. Monoklonale TBL-Antikörper sind mit zahlreichen experimentellen Techniken kompatibel, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). TBL (T-Zell-Leukämie/Lymphom 1) spielt eine entscheidende Rolle bei der Regulierung der Genexpression und ist an mehreren zellulären Prozessen beteiligt, darunter Zellproliferation und -differenzierung. Eine Dysregulation von TBL wurde mit verschiedenen Krebsarten in Verbindung gebracht, was es zu einem wichtigen Ziel für therapeutische Interventionen und die Entdeckung von Biomarkern macht. Das Verständnis der TBL-Funktion ist für den Fortschritt in der Krebsforschung und die Entwicklung wirksamer Behandlungen von entscheidender Bedeutung. Forscher können monoklonale TBL-Antikörper zur Untersuchung von Proteinexpressionsmustern in verschiedenen Gewebetypen und unter verschiedenen Versuchsbedingungen einsetzen. Zu den fortschrittlichen Visualisierungsoptionen gehören die Konjugation mit Meerrettichperoxidase (HRP), Phycoerythrin (PE) und Fluoresceinisothiocyanat (FITC) für eine erhöhte Flexibilität bei der Detektion. Die monoklonalen TBL-Antikörper von Santa Cruz Biotechnology unterstützen Forscher auf der ganzen Welt bei ihrer Aufgabe, das wissenschaftliche Verständnis voranzutreiben und innovative therapeutische Strategien zu entwickeln.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
TBL Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
TBL1 Antikörper (H-3) | sc-137006 | mouse IgG1 κ | 211-577 (h) | WB, IP, IF, ELISA | m, r, h | 5 | ||
TBL1 Antikörper (A-3) | sc-137082 | mouse IgG1 κ | 211-577 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
TBL1 Antikörper (H-11) | sc-137083 | mouse IgG1 κ | 211-577 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 1 | ||
TBL1X Antikörper (F-2) | sc-365661 | mouse IgG1 | 119-148 (h) | WB, IP, IF, ELISA | h | 2 | ||
TBL1XR1 Antikörper (L-08) | sc-100908 | mouse IgG1 κ | 81-179 (h) | WB, IP, IF, IHC(P), ELISA | h | 13 |
TBL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TBL1X CRISPR/Cas9 KO Plasmid (h) | sc-403623 | h | Gene Knockout | GFP | 0 | ||
TBL1X HDR Plasmid (h) | sc-403623-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TBL1X Double Nickase Plasmid (h) | sc-403623-NIC | h | Gene Knockout | Puromycin | 0 | ||
TBL1X Double Nickase Plasmid (h2) | sc-403623-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TBL1X CRISPR/Cas9 KO Plasmid (m) | sc-423272 | m | Gene Knockout | GFP | 0 | ||
TBL1X HDR Plasmid (m) | sc-423272-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TBL1X Double Nickase Plasmid (m) | sc-423272-NIC | m | Gene Knockout | Puromycin | 0 | ||
TBL1X Double Nickase Plasmid (m2) | sc-423272-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TBL1Y CRISPR/Cas9 KO Plasmid (h) | sc-404389 | h | Gene Knockout | GFP | 0 | ||
TBL1Y HDR Plasmid (h) | sc-404389-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TBL1Y Double Nickase Plasmid (h) | sc-404389-NIC | h | Gene Knockout | Puromycin | 0 | ||
TBL1Y Double Nickase Plasmid (h2) | sc-404389-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TBL3 CRISPR/Cas9 KO Plasmid (h) | sc-411490 | h | Gene Knockout | GFP | 0 | ||
TBL3 HDR Plasmid (h) | sc-411490-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TBL3 Double Nickase Plasmid (h) | sc-411490-NIC | h | Gene Knockout | Puromycin | 0 | ||
TBL3 Double Nickase Plasmid (h2) | sc-411490-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TBL3 CRISPR/Cas9 KO Plasmid (m) | sc-431894 | m | Gene Knockout | GFP | 0 | ||
TBL3 HDR Plasmid (m) | sc-431894-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TBL3 Double Nickase Plasmid (m) | sc-431894-NIC | m | Gene Knockout | Puromycin | 0 | ||
TBL3 Double Nickase Plasmid (m2) | sc-431894-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TBL1XR1 CRISPR/Cas9 KO Plasmid (h) | sc-401998 | h | Gene Knockout | GFP | 1 | ||
TBL1XR1 CRISPR/Cas9 KO Plasmid (h2) | sc-401998-KO-2 | h | Gene Knockout | GFP | 1 | ||
TBL1XR1 HDR Plasmid (h2) | sc-401998-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
TBL1XR1 Double Nickase Plasmid (h) | sc-401998-NIC | h | Gene Knockout | Puromycin | 1 | ||
TBL1XR1 Double Nickase Plasmid (h2) | sc-401998-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
TBL1XR1 CRISPR/Cas9 KO Plasmid (m) | sc-429866 | m | Gene Knockout | GFP | 0 | ||
TBL1XR1 HDR Plasmid (m) | sc-429866-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TBL1XR1 Double Nickase Plasmid (m) | sc-429866-NIC | m | Gene Knockout | Puromycin | 0 | ||
TBL1XR1 Double Nickase Plasmid (m2) | sc-429866-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TBL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TBL1X CRISPR Activation Plasmid (h) | sc-403623-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X CRISPR Activation Plasmid (h2) | sc-403623-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X Lentiviral Activation Particles (h) | sc-403623-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X Lentiviral Activation Particles (h2) | sc-403623-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X CRISPR Activation Plasmid (m) | sc-423272-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X CRISPR Activation Plasmid (m2) | sc-423272-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X Lentiviral Activation Particles (m) | sc-423272-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1X Lentiviral Activation Particles (m2) | sc-423272-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1Y CRISPR Activation Plasmid (h) | sc-404389-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1Y CRISPR Activation Plasmid (h2) | sc-404389-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1Y Lentiviral Activation Particles (h) | sc-404389-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1Y Lentiviral Activation Particles (h2) | sc-404389-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 CRISPR Activation Plasmid (h) | sc-411490-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 CRISPR Activation Plasmid (h2) | sc-411490-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 Lentiviral Activation Particles (h) | sc-411490-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 Lentiviral Activation Particles (h2) | sc-411490-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 CRISPR Activation Plasmid (m) | sc-431894-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 CRISPR Activation Plasmid (m2) | sc-431894-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 Lentiviral Activation Particles (m) | sc-431894-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL3 Lentiviral Activation Particles (m2) | sc-431894-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1XR1 CRISPR Activation Plasmid (h) | sc-401998-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TBL1XR1 CRISPR Activation Plasmid (h2) | sc-401998-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TBL1XR1 Lentiviral Activation Particles (h) | sc-401998-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TBL1XR1 Lentiviral Activation Particles (h2) | sc-401998-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TBL1XR1 CRISPR Activation Plasmid (m) | sc-429866-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1XR1 CRISPR Activation Plasmid (m2) | sc-429866-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1XR1 Lentiviral Activation Particles (m) | sc-429866-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TBL1XR1 Lentiviral Activation Particles (m2) | sc-429866-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
TBL siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TBL1X siRNA (h) | sc-38888 | h | Gene Silencing | N/A | 0 | ||
TBL1X shRNA Plasmid (h) | sc-38888-SH | h | Gene Silencing | Puromycin | 0 | ||
TBL1X shRNA (h) Lentivirale Partikel | sc-38888-V | h | Gene Silencing | Puromycin | 0 | ||
TBL1X siRNA (m) | sc-38889 | m | Gene Silencing | N/A | 0 | ||
TBL1X shRNA Plasmid (m) | sc-38889-SH | m | Gene Silencing | Puromycin | 0 | ||
TBL1X shRNA (m) Lentivirale Partikel | sc-38889-V | m | Gene Silencing | Puromycin | 0 | ||
TBL1Y siRNA (h) | sc-91549 | h | Gene Silencing | N/A | 0 | ||
TBL1Y shRNA Plasmid (h) | sc-91549-SH | h | Gene Silencing | Puromycin | 0 | ||
TBL1Y shRNA (h) Lentivirale Partikel | sc-91549-V | h | Gene Silencing | Puromycin | 0 | ||
TBL3 siRNA (h) | sc-93384 | h | Gene Silencing | N/A | 0 | ||
TBL3 shRNA Plasmid (h) | sc-93384-SH | h | Gene Silencing | Puromycin | 0 | ||
TBL3 shRNA (h) Lentivirale Partikel | sc-93384-V | h | Gene Silencing | Puromycin | 0 | ||
TBL3 siRNA (m) | sc-154121 | m | Gene Silencing | N/A | 0 | ||
TBL3 shRNA Plasmid (m) | sc-154121-SH | m | Gene Silencing | Puromycin | 0 | ||
TBL3 shRNA (m) Lentivirale Partikel | sc-154121-V | m | Gene Silencing | Puromycin | 0 | ||
TBL1XR1 siRNA (h) | sc-106601 | h | Gene Silencing | N/A | 1 | ||
TBL1XR1 shRNA Plasmid (h) | sc-106601-SH | h | Gene Silencing | Puromycin | 1 | ||
TBL1XR1 shRNA (h) Lentivirale Partikel | sc-106601-V | h | Gene Silencing | Puromycin | 1 | ||
TBL1XR1 siRNA (m) | sc-154120 | m | Gene Silencing | N/A | 1 | ||
TBL1XR1 shRNA Plasmid (m) | sc-154120-SH | m | Gene Silencing | Puromycin | 1 | ||
TBL1XR1 shRNA (m) Lentivirale Partikel | sc-154120-V | m | Gene Silencing | Puromycin | 1 |